These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22406108)

  • 21. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
    Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
    Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.
    Blome S; Aebischer A; Lange E; Hofmann M; Leifer I; Loeffen W; Koenen F; Beer M
    Vet Microbiol; 2012 Jul; 158(1-2):42-59. PubMed ID: 22397931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
    von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
    Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
    Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
    Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
    Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
    Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
    Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
    Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
    Kaden V; Schurig U; Steyer H
    Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.
    Pannhorst K; Fröhlich A; Staubach C; Meyer D; Blome S; Becher P
    J Vet Diagn Invest; 2015 Jul; 27(4):449-60. PubMed ID: 26179095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.
    Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F
    Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.
    Koenig P; Hoffmann B; Depner KR; Reimann I; Teifke JP; Beer M
    Vet Microbiol; 2007 Mar; 120(3-4):343-51. PubMed ID: 17147979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.
    Frey CF; Bauhofer O; Ruggli N; Summerfield A; Hofmann MA; Tratschin JD
    Vet Res; 2006; 37(5):655-70. PubMed ID: 16777037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.
    Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn
    Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S
    Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of C-strain "Riems" or CP7_E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR.
    Leifer I; Depner K; Blome S; Le Potier MF; Le Dimna M; Beer M; Hoffmann B
    J Virol Methods; 2009 Jun; 158(1-2):114-22. PubMed ID: 19428579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of safety and protective value of a cell culture modified strain "C" vaccine of hog cholera/classical swine fever virus.
    Dahle J; Liess B
    Berl Munch Tierarztl Wochenschr; 1995 Jan; 108(1):20-5. PubMed ID: 7779071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals.
    Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ
    J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
    Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
    Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals.
    Farsang A; Lévai R; Barna T; Fábián K; Blome S; Belák K; Bálint Á; Koenen F; Kulcsár G
    Biologicals; 2017 Jan; 45():85-92. PubMed ID: 27756679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.